The Cannigma

APRIL 7, 2022

I mean, it’s really interesting to see a lot of these sativas out there. I think that terpenes it’s probably less pharmacological than we think and it’s classically associated with a lot of sativas. So you look at these studies on CBD and epilepsy, I mean they’re not taking ten milligrams.

Terpenes 52

Terpenes Wellness and Beauty Cannabis Extraction 52

Cannabis Law Report

NOVEMBER 24, 2021

Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. Refractory paediatric epilepsy. Conclusions. 2018 ; Frankhauser 2008 ). Palliative care indications. Cancer pain. Neuropathic pain. 2019 ; Sarris et al.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

SEPTEMBER 23, 2019

In this position paper, cannabis is an overarching term used to refer to the plant Cannabis sativa. The cannabis plant, Cannabis sativa , is comprised of both non-psychoactive and psychoactive chemicals called cannabinoids. Cannabis sativa with less than 0.3% J Epilepsy Res. Call to Action. and 2.3%, respectively.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

The Cannigma

DECEMBER 22, 2021

We have autism and epilepsy. When we divide oils, for example, between day and night, or sativa and indica, we do address these type of indications as well. Because it’s not in the list and the doctors wants to give the prescription. Cannabis is given to oncology patients, palliative patients. It’s about the formulation.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79